speb/financial-data huggingface dataset:
Stock screener scorecard for FTG.TO (quarterly, report date 2026-05-31)
Altman Z-score: 6.606183970380535 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 7.883223616960379%
Earnings yield: 0.7949470175135577%
Return on net tangible assets: 10.372492836676217%
Capitalized R&D asset: 3895064.1988182133
ROCI (R&D adjusted): 5.603469915303446%
Rosenberg metric: 1.9542886976650582
Free cash flow margin: 6.4226794349104015%
Revenue growth: 10.673224925673487%
Rule of 40 score: 17.095904360583887
Market cap: 581001856 (Small Cap ($300M-$2B))
P/E ratio: 32.27708179808401
Debt to equity: 0.3555
Free cash flow (dilution adjusted): 2454347.8260869565
Operating income: 5588405.79710145
Net income: 3690579.7101449277
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for IFCN.SW (annual, report date 2025-12-31)
Altman Z-score: 19.34396279918628 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 27.185333523823818%
Earnings yield: 3.6679856631460277%
Return on net tangible assets: 20.368517394438335%
Capitalized R&D asset: 127526392.31464738
ROCI (R&D adjusted): 22.093727013752172%
Rosenberg metric: 0.5491884986285256
Free cash flow margin: 10.063008839049154%
Revenue growth: 14.39285222556523%
Rule of 40 score: 24.455861064614382
Market cap: 3955584256 (Mid Cap ($2B-$10B))
P/E ratio: 43.055678498716475
Debt to equity: 0.11869999999999999
Free cash flow (dilution adjusted): 85817721.51898734
Operating income: 142110126.58227846
Net income: 108627848.10126582
Long score: 12 | Short score: 1
Recommendation: Long
Stock screener scorecard for ISGEC.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.2676165194925053 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 2.476315094880017%
Earnings yield: 0.013445988712030517%
Return on net tangible assets: 5.688268993510729%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.3645396802415215%
Revenue growth: 12.083822597245543%
Rule of 40 score: 12.083822597245543
Market cap: 62911848448 (Large Cap ($10B-$200B))
P/E ratio: 0.6151036791225429
Debt to equity: 0.3293
Operating income: 9346121.237812633
Net income: 9004874.947011445
Long score: 2 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ISGEC.NS (annual, report date 2026-03-31)
Altman Z-score: 1.9314703093240546 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 7.760842828822859%
Earnings yield: 0.04214011588749421%
Return on net tangible assets: 10.102538680303704%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.41053546005164%
Free cash flow margin: 8.788733971007149%
Revenue growth: -4.20784436701242%
Rule of 40 score: 4.580889603994729
Market cap: 62911848448 (Large Cap ($10B-$200B))
P/E ratio: 0.6151036791225429
Debt to equity: 0.3293
Free cash flow (dilution adjusted): 63235481.13607461
Operating income: 29291013.14116151
Net income: 16324713.86180585
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for KDDL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 3.6179994006258775 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 2.558818646170073%
Earnings yield: 0.012422717471634846%
Return on net tangible assets: 6.482734786740778%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.2923538624412694%
Revenue growth: -8.328784361717164%
Rule of 40 score: -8.328784361717164
Market cap: 38560702464 (Large Cap ($10B-$200B))
P/E ratio: 0.2990461343460478
Debt to equity: 0.2669
Operating income: 5553200.5086901225
Net income: 3660449.3429419245
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for KDDL.NS (annual, report date 2026-03-31)
Altman Z-score: 4.351494632601949 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 9.102362512330185%
Earnings yield: 0.04419073543344915%
Return on net tangible assets: 10.843917096257044%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.154480151890317%
Free cash flow margin: -0.18064204548093044%
Revenue growth: 18.464026506784485%
Rule of 40 score: 18.283384461303555
Market cap: 38560702464 (Large Cap ($10B-$200B))
P/E ratio: 0.2990461343460478
Debt to equity: 0.2669
Free cash flow (dilution adjusted): -412250.95379398053
Operating income: 19754133.107248835
Net income: 14325985.587113183
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MACF.L (annual, report date 2025-12-31)
Altman Z-score: 1.955750146042046 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 17.918602650146276%
Earnings yield: 9.346962456441974%
Return on net tangible assets: 127.96084202444176%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.90285726913133%
Free cash flow margin: 6.690602041155547%
Revenue growth: 20.249817887345298%
Rule of 40 score: 26.940419928500845
Market cap: 104146240 (Micro Cap ($50M-$300M))
P/E ratio: 0.23310810810810811
Debt to equity: 0.7412000000000001
Free cash flow (dilution adjusted): 27197297.2972973
Operating income: 16885135.135135137
Net income: 8535135.135135135
Long score: 9 | Short score: 2
Recommendation: Long
Stock screener scorecard for MRF.NS (annual, report date 2026-03-31)
Altman Z-score: 4.549631897380384 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 16.08982957570213%
Earnings yield: 0.06390048262733553%
Return on net tangible assets: 13.142579510191066%
Capitalized R&D asset: 11243126.240419786
ROCI (R&D adjusted): 13.989542123950121%
Rosenberg metric: 4.650744589969902
Free cash flow margin: 10.20329649191266%
Revenue growth: 0.23460691773932274%
Rule of 40 score: 10.437903409651982
Market cap: 554550624256 (Mega Cap (>= $200B))
P/E ratio: 0.23684962772155807
Debt to equity: 0.15289999999999998
Free cash flow (dilution adjusted): 334469054.68418825
Operating income: 341442348.45273423
Net income: 257111064.0101738
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for MRF.NS (quarterly, report date 2026-03-31)
Altman Z-score: 3.589752278521611 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 4.309997832616032%
Earnings yield: 0.017117082585066234%
Return on net tangible assets: 5.45973637714734%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.7609751760996097%
Revenue growth: -4.937735739641124%
Rule of 40 score: -4.937735739641124
Market cap: 554550624256 (Mega Cap (>= $200B))
P/E ratio: 0.23684962772155807
Debt to equity: 0.15289999999999998
Operating income: 91462484.10343365
Net income: 74422424.75625265
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MTLA.DE (quarterly, report date 2026-03-31)
Altman Z-score: 2.639517245941562 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 26.87326549491212%
Earnings yield: 0.8447320717233497%
Return on net tangible assets: -6.904020576688777%
Capitalized R&D asset: 511110000
ROCI (R&D adjusted): 4.133376947586642%
Rosenberg metric: -1.5037037037037038
Free cash flow margin: 10.648489314664701%
Revenue growth: -19.704142011834318%
Rule of 40 score: -9.055652697169617
Market cap: 60057198592 (Large Cap ($10B-$200B))
P/E ratio: 39.41188267207075
Debt to equity: 3.7413
Free cash flow (dilution adjusted): 289000000
Operating income: 581000000
Net income: 368000000
Long score: 6 | Short score: 10
Recommendation: Neutral
Stock screener scorecard for OFSS.NS (annual, report date 2026-03-31)
Altman Z-score: 28.476375198794692 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 53.11103206149374%
Earnings yield: 0.041685314324510205%
Return on net tangible assets: 36.759123278561326%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 40.322201869334464%
Free cash flow margin: 32.03816425750446%
Revenue growth: 1.579934068703975%
Rule of 40 score: 33.61809832620844
Market cap: 887272570880 (Mega Cap (>= $200B))
P/E ratio: 0.22867493222040952
Debt to equity: 0.0042
Free cash flow (dilution adjusted): 260491733.78550234
Operating income: 363925392.1153031
Net income: 279705383.6371344
Long score: 15 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for PAGEIND.NS (annual, report date 2026-03-31)
Altman Z-score: 23.9805774915398 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 63.196131948548725%
Earnings yield: 0.025183179542798757%
Return on net tangible assets: 50.915954420704765%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 60.84590603827258%
Free cash flow margin: 13.133774201990493%
Revenue growth: -3.549747450847171%
Rule of 40 score: 9.584026751143321
Market cap: 449222279168 (Mega Cap (>= $200B))
P/E ratio: 0.4877274391581995
Debt to equity: 0.18420000000000003
Free cash flow (dilution adjusted): 72757100.46629928
Operating income: 112752119.54217888
Net income: 80947753.28529038
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for PAGEIND.NS (quarterly, report date 2026-03-31)
Altman Z-score: 21.628542511685882 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 13.811129557746051%
Earnings yield: 0.005503630437773349%
Return on net tangible assets: 13.790417943596122%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.297502005932873%
Revenue growth: -14.06796548239104%
Rule of 40 score: -14.06796548239104
Market cap: 449222279168 (Mega Cap (>= $200B))
P/E ratio: 0.4877274391581995
Debt to equity: 0.18420000000000003
Operating income: 24641288.681644764
Net income: 18941331.07248834
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for PDEX (quarterly, report date 2026-03-31)
Altman Z-score: 5.405172560279243 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 6.029896123638206%
Earnings yield: 1.676317429462253%
Return on net tangible assets: 11.035009615131319%
Capitalized R&D asset: 1572220
ROCI (R&D adjusted): 5.079152185376025%
Rosenberg metric: 0.5313351498637602
Free cash flow margin: 6.692064765151136%
Revenue growth: 6.890639232706425%
Rule of 40 score: 13.58270399785756
Market cap: 175378256 (Micro Cap ($50M-$300M))
P/E ratio: 13.53168044077135
Debt to equity: 0.44630000000000003
Free cash flow (dilution adjusted): 1335000
Operating income: 3094000
Net income: 3938000
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for PHM.MC (quarterly, report date 2026-03-31)
Altman Z-score: 7.586838932336186 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0.2550413724670128%
Earnings yield: 0.05730217761800474%
Return on net tangible assets: 0.92280412069253%
Capitalized R&D asset: 34160924.67883705
ROCI (R&D adjusted): 1.7219532908555208%
Free cash flow margin: 16.865194992890274%
Revenue growth: -67.33981446898308%
Rule of 40 score: -50.474619476092805
Market cap: 1365122176 (Small Cap ($300M-$2B))
P/E ratio: 21.483305966064584
Debt to equity: 0.19039999999999999
Free cash flow (dilution adjusted): 8316091.954022989
Operating income: 714942.5287356322
Net income: 1762068.9655172413
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for QDT.PA (annual, report date 2026-01-31)
Altman Z-score: 0.7910340171840313 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 68.01736613603471%
Earnings yield: 15.269944802926089%
Capitalized R&D asset: 137927303.3126294
ROCI (R&D adjusted): 7.881100270058039%
Rosenberg metric: 1.0152411282984544
Free cash flow margin: 4.113160181519745%
Revenue growth: 8.333987081927782%
Rule of 40 score: 12.447147263447526
Market cap: 404653952 (Small Cap ($300M-$2B))
Debt to equity: 0.8251999999999999
Free cash flow (dilution adjusted): 50714285.71428572
Operating income: 167857142.85714287
Net income: -77976190.47619048
Long score: 8 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for RCT.AX (annual, report date 2025-12-31)
Altman Z-score: 0.6996363889014878 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 11.168039098917799%
Earnings yield: 7.865786664004798%
Return on net tangible assets: 30.056272757365115%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.07039988600857%
Free cash flow margin: 32.783373421527365%
Revenue growth: 13.919193971379041%
Rule of 40 score: 46.7025673929064
Market cap: 191235968 (Micro Cap ($50M-$300M))
P/E ratio: 10.524710189139721
Debt to equity: 0.0821
Free cash flow (dilution adjusted): 5854362.416107383
Operating income: 7300000
Net income: 3630872.4832214764
Long score: 8 | Short score: 3
Recommendation: Long
Stock screener scorecard for RVTY (quarterly, report date 2026-03-31)
Altman Z-score: 2.415590216098899 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 4.9972243495989295%
Earnings yield: 0.5122632730469292%
Return on net tangible assets: -7.885122611405296%
Capitalized R&D asset: 113627930
ROCI (R&D adjusted): 0.718874750824603%
Rosenberg metric: -0.584502200220022
Free cash flow margin: 12.197694334836132%
Revenue growth: -7.892950770410437%
Rule of 40 score: 4.304743564425696
Market cap: 12324008960 (Large Cap ($10B-$200B))
P/E ratio: 42.08653846153846
Debt to equity: 0.4664
Free cash flow (dilution adjusted): 86740000
Operating income: 75886000
Net income: 40718000
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for SM.V (quarterly, report date 2026-03-31)
Altman Z-score: 12.549967684676115 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 2.926897440591351%
Earnings yield: 0.45602870831088405%
Return on net tangible assets: -3.233495243727914%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.6407075413828296%
Free cash flow margin: 1.725483220481225%
Revenue growth: 7.8534401376431795%
Rule of 40 score: 9.578923358124404
Market cap: 263651072 (Micro Cap ($50M-$300M))
P/E ratio: 18.19116135662898
Debt to equity: 0.052199999999999996
Free cash flow (dilution adjusted): 125476.97841726616
Operating income: 1155197.8417266188
Net income: 243769.06474820146
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for TORNTPHARM.NS (annual, report date 2026-03-31)
Altman Z-score: 4.8315123528544 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 53.39020407656441%
Earnings yield: 0.019207689585154435%
Return on net tangible assets: -13.186309323564958%
Capitalized R&D asset: 8124988.342174613
ROCI (R&D adjusted): 9.569107861981072%
Rosenberg metric: 27.583877154066617
Free cash flow margin: 17.05316443915105%
Revenue growth: 10.163450754943113%
Rule of 40 score: 27.216615194094164
Market cap: 1887195234304 (Mega Cap (>= $200B))
P/E ratio: 0.6943431499261448
Debt to equity: 0.8545
Free cash flow (dilution adjusted): 248550233.14963967
Operating income: 364535820.2628232
Net income: 229267698.17719373
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for TORNTPHARM.NS (quarterly, report date 2026-03-31)
Altman Z-score: 4.42128906325042 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 13.16222441592629%
Earnings yield: 0.004735249194191152%
Return on net tangible assets: -4.470526669906179%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.357609950670904%
Revenue growth: 20.799743490410695%
Rule of 40 score: 20.799743490410695
Market cap: 1887195234304 (Mega Cap (>= $200B))
P/E ratio: 0.6943431499261448
Debt to equity: 0.8545
Operating income: 89868588.38490885
Net income: 41225095.37939805
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for TRE.MC (quarterly, report date 2026-03-31)
Altman Z-score: 0.7001533907002758 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 6.888425632194324%
Earnings yield: 4.470447553991138%
Return on net tangible assets: 4.2805569881382155%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.961483222352787%
Revenue growth: -16.777738812030986%
Rule of 40 score: -16.777738812030986
Market cap: 2303861760 (Mid Cap ($2B-$10B))
P/E ratio: 19.237084754326133
Debt to equity: 1.5944
Operating income: 87356321.83908045
Net income: 17126436.781609196
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for VIV (quarterly, report date 2026-03-31)
Altman Z-score: 1.4277440756491182 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 5.094986111624587%
Earnings yield: 1.4259292240143318%
Return on net tangible assets: 13.274879484126748%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.3885955849226383%
Free cash flow margin: 13.31028936799944%
Revenue growth: 3.773109330117856%
Rule of 40 score: 17.083398698117296
Market cap: 22449133568 (Large Cap ($10B-$200B))
P/E ratio: 19.5
Debt to equity: 0.2848
Free cash flow (dilution adjusted): 548409125.4752852
Operating income: 474223193.9163498
Net income: 239749619.77186313
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for XTC.TO (quarterly, report date 2026-03-31)
Altman Z-score: 2.1920718704999285 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 2.2230600094630595%
Earnings yield: 1.6787447119732644%
Return on net tangible assets: 3.243279390129731%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.687379606636591%
Free cash flow margin: 3.0191864634835204%
Revenue growth: 3.858939840810718%
Rule of 40 score: 6.878126304294238
Market cap: 300404192 (Small Cap ($300M-$2B))
P/E ratio: 8.564576909900651
Debt to equity: 0.24280000000000002
Free cash flow (dilution adjusted): 3422302.1582733816
Operating income: 6320863.309352518
Net income: 4164748.2014388493
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for ZAP.OL (quarterly, report date 2026-03-31)
Altman Z-score: 5.716778486505203 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 6.7193871918881%
Earnings yield: 0.12015656573540778%
Return on net tangible assets: 2.121861329452967%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.83523365691024%
Free cash flow margin: 13.601854141726285%
Revenue growth: 9.091182181486237%
Rule of 40 score: 22.693036323212525
Market cap: 4007307520 (Mid Cap ($2B-$10B))
P/E ratio: 3.066306766203991
Debt to equity: 0.0751
Free cash flow (dilution adjusted): 6387461.459403905
Operating income: 4316546.762589928
Net income: 1922404.9331963
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3498.T (annual, report date 2025-08-31)
Altman Z-score: 3.604607270736493 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 31.427290985443264%
Earnings yield: 0.05624697370455866%
Return on net tangible assets: 17.897528968309377%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 23.17985382515334%
Free cash flow margin: -0.32331271178537013%
Revenue growth: 45.013205098042306%
Rule of 40 score: 44.689892386256936
Market cap: 227229028720 (Mega Cap (>= $200B))
P/E ratio: 20.00431628840567
Debt to equity: 1.8031576466891839
Free cash flow (dilution adjusted): -2125485.3872879627
Operating income: 128986988.21445604
Net income: 77382655.49424349
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8015.T (annual, report date 2025-03-31)
Altman Z-score: 2.7516153271417205 (Grey Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 17.415566347618842%
Earnings yield: 0.042609983577423606%
Return on net tangible assets: 15.923679985691594%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.104519592690062%
Free cash flow margin: 3.032392296462988%
Revenue growth: 2.414156552459248%
Rule of 40 score: 5.446548848922236
Market cap: 2569621864126.32 (Mega Cap (>= $200B))
P/E ratio: 6.6185404720881085
Debt to equity: 0.6751349859168881
Free cash flow (dilution adjusted): 2089466648.8437374
Operating income: 3341612083.9459963
Net income: 2594880363.5877557
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for 9603.T (annual, report date 2025-10-31)
Altman Z-score: 1.1581123151711847 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 11.91588785046729%
Earnings yield: 0.04660379390368807%
Return on net tangible assets: 24.945639043247166%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.084937735967127%
Free cash flow margin: 3.769706196094407%
Revenue growth: 8.177157422049014%
Rule of 40 score: 11.946863618143421
Market cap: 97867248863.99998 (Large Cap ($10B-$200B))
P/E ratio: 16.967276155339803
Debt to equity: 2.6645884173561103
Free cash flow (dilution adjusted): 91390513.32033788
Operating income: 75555555.55555555
Net income: 37478882.39116309
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ARGX.BR (annual, report date 2025-12-31)
Altman Z-score: 21.276782937156085 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 18.741497716878744%
Earnings yield: 2.753563552714953%
Return on net tangible assets: 18.63528648250621%
Capitalized R&D asset: 2606355545.220588
ROCI (R&D adjusted): 14.650466852397614%
Rosenberg metric: 2.2564685617002462
Free cash flow margin: 7.835185032702682%
Revenue growth: 114.1779307887669%
Rule of 40 score: 122.01311582146958
Market cap: 44576194252.799995 (Large Cap ($10B-$200B))
P/E ratio: 34.50076371986827
Debt to equity: 0.006439902707763334
Free cash flow (dilution adjusted): 382862352.9411765
Operating income: 1240723529.4117646
Net income: 1520041176.4705882
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for DASH (annual, report date 2025-12-31)
Altman Z-score: 6.4787546921662065 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 18.125%
Earnings yield: 0.9917090293102252%
Return on net tangible assets: 63.2209405501331%
Capitalized R&D asset: 2544550000
ROCI (R&D adjusted): 5.94980449307811%
Rosenberg metric: 1.5402397260273972
Free cash flow margin: 5.649923452649997%
Revenue growth: 27.933221413915316%
Rule of 40 score: 33.58314486656531
Market cap: 93159515432.8 (Large Cap ($10B-$200B))
P/E ratio: 99.63584538267379
Debt to equity: 0.32749352976308976
Free cash flow (dilution adjusted): 775000000
Operating income: 725000000
Net income: 935000000
Long score: 12 | Short score: 1
Recommendation: Long
Stock screener scorecard for FTG.TO (annual, report date 2025-11-30)
Altman Z-score: 4.6315021152806874 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 22.540801913540154%
Earnings yield: 2.221426604973742%
Return on net tangible assets: 31.920413795382807%
Capitalized R&D asset: 12757934.24369748
ROCI (R&D adjusted): 16.16805973837458%
Rosenberg metric: 2.321976149914821
Free cash flow margin: 6.656160338436407%
Revenue growth: 17.828940874543488%
Rule of 40 score: 24.485101212979895
Market cap: 285717976.5 (Micro Cap ($50M-$300M))
P/E ratio: 21.424563324835034
Debt to equity: 0.444012738197071
Free cash flow (dilution adjusted): 9080714.285714285
Operating income: 15616428.571428573
Net income: 9525714.285714285
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for MTLA.DE (annual, report date 2025-12-31)
Altman Z-score: 3.515375070546483 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 150.3556910569106%
Earnings yield: 4.302172461668488%
Return on net tangible assets: -30.958099813183882%
Capitalized R&D asset: 1867530000
ROCI (R&D adjusted): 19.856995374387377%
Rosenberg metric: 0.5703380588876772
Free cash flow margin: 19.50864577983222%
Revenue growth: 7.996671905334196%
Rule of 40 score: 27.505317685166418
Market cap: 62517841959.6 (Large Cap ($10B-$200B))
P/E ratio: 28.943445351666668
Debt to equity: 4.023897816234034
Free cash flow (dilution adjusted): 2279000000
Operating income: 2959000000
Net income: 2160000000
Long score: 9 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for PDEX (annual, report date 2025-06-30)
Altman Z-score: 6.555564418092292 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 23.790340529712886%
Earnings yield: 5.791259535721403%
Return on net tangible assets: 24.506911435283833%
Capitalized R&D asset: 6697950
ROCI (R&D adjusted): 20.869573924861147%
Rosenberg metric: 1.5550329256820319
Free cash flow margin: -5.1155891078929585%
Revenue growth: 23.26381345499312%
Rule of 40 score: 18.14822434710016
Market cap: 139332002.76 (Micro Cap ($50M-$300M))
P/E ratio: 15.51926963243484
Debt to equity: 0.4525278445075344
Free cash flow (dilution adjusted): -3483000
Operating income: 10689000
Net income: 8978000
Long score: 10 | Short score: 2
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for PHM.MC (annual, report date 2025-12-31)
Altman Z-score: 7.835042876336615 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 24.01446611157169%
Earnings yield: 5.653923602748758%
Return on net tangible assets: 30.828963372884488%
Capitalized R&D asset: 220635915.93137255
ROCI (R&D adjusted): 12.606296973791142%
Rosenberg metric: 0.6716960286075742
Free cash flow margin: 19.617417227517052%
Revenue growth: 42.99875358910828%
Rule of 40 score: 62.616170816625335
Market cap: 1281967416 (Small Cap ($300M-$2B))
P/E ratio: 17.096090150161363
Debt to equity: 0.19622130538888866
Free cash flow (dilution adjusted): 51095294.11764706
Operating income: 70542352.94117647
Net income: 88218823.52941176
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for RVTY (annual, report date 2025-12-31)
Altman Z-score: 2.4326027670975483 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 22.961468308106742%
Earnings yield: 2.407440270709902%
Return on net tangible assets: -33.50721813937605%
Capitalized R&D asset: 419196220
ROCI (R&D adjusted): 3.222364607094583%
Rosenberg metric: 0.13567088659039644
Free cash flow margin: 17.03625040309154%
Revenue growth: 3.6669345407266576%
Rule of 40 score: 20.703184943818197
Market cap: 10778905267.26 (Large Cap ($10B-$200B))
P/E ratio: 44.68847669478982
Debt to equity: 0.46869493376880594
Free cash flow (dilution adjusted): 486564000
Operating income: 356635000
Net income: 241201000
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for SM.V (annual, report date 2025-12-31)
Altman Z-score: 9.339329817833715 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 6.9939787291037945%
Earnings yield: 1.0323317074541425%
Return on net tangible assets: 8.124902363623665%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.274386242654299%
Free cash flow margin: -10.135534599839218%
Revenue growth: 295.8439856192466%
Rule of 40 score: 285.7084510194074
Market cap: 336450239.46 (Small Cap ($300M-$2B))
P/E ratio: 41.360589644604055
Debt to equity: 0.10974680910897291
Free cash flow (dilution adjusted): -1846272.2627737224
Operating income: 2615070.8029197077
Net income: 5937635.766423358
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for TRE.MC (annual, report date 2025-12-31)
Altman Z-score: 1.8056912283730606 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 30.739724890988185%
Earnings yield: 17.84720237707972%
Return on net tangible assets: 35.14045470892687%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 20.725033960623158%
Free cash flow margin: 1.9421403755357374%
Revenue growth: 64.05037453659142%
Rule of 40 score: 65.99251491212716
Market cap: 2158493975 (Mid Cap ($2B-$10B))
P/E ratio: 13.771438620108844
Debt to equity: 1.603783494143073
Free cash flow (dilution adjusted): 147736470.5882353
Operating income: 348749411.7647059
Net income: 184396470.5882353
Long score: 10 | Short score: 2
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for VIV (annual, report date 2025-12-31)
Altman Z-score: 1.9020262447961187 (Grey Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 20.910697230363084%
Earnings yield: 5.430633832843126%
Return on net tangible assets: 58.308513567852025%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.625311939703396%
Free cash flow margin: 13.670630471567605%
Revenue growth: 20.989195249562894%
Rule of 40 score: 34.6598257211305
Market cap: 98854804256.5792 (Large Cap ($10B-$200B))
P/E ratio: 16.002285092403113
Debt to equity: 0.29486778536836356
Free cash flow (dilution adjusted): 2054716240.8759122
Operating income: 1806073175.1824815
Net income: 1127288868.6131387
Long score: 12 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for XTC.TO (annual, report date 2025-09-30)
Altman Z-score: 2.909552365304241 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 8.603303140065941%
Earnings yield: 6.471555132544328%
Return on net tangible assets: 8.667405835656519%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.4874866400297275%
Free cash flow margin: 4.767554687995215%
Revenue growth: -6.308243620863633%
Rule of 40 score: -1.5406889328684183
Market cap: 241376078.40000004 (Micro Cap ($50M-$300M))
P/E ratio: 9.936443207640377
Debt to equity: 0.23849478207489253
Free cash flow (dilution adjusted): 21102877.697841726
Operating income: 24366906.474820144
Net income: 17476258.992805757
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for ZAP.OL (annual, report date 2025-12-31)
Altman Z-score: 5.040396424997764 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 13.791607414013352%
Earnings yield: 0.23773006420443396%
Return on net tangible assets: 16.062427210425348%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.89390250650141%
Free cash flow margin: 24.422817955193608%
Revenue growth: 36.31427051805098%
Rule of 40 score: 60.73708847324459
Market cap: 2084481615.7604585 (Mid Cap ($2B-$10B))
P/E ratio: 38.681022393446874
Debt to equity: 0.06554689188690485
Free cash flow (dilution adjusted): 37228855.721393034
Operating income: 8540298.507462686
Net income: 5362089.552238805
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 0144.HK (annual, report date 2025-12-31)
Altman Z-score: 0.866274643651708 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 22.727069251085545%
Earnings yield: 0.6273138230831118%
Return on net tangible assets: 10.270520179068795%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.3565610620405146%
Free cash flow margin: 64.3926913284409%
Revenue growth: 12.47822117173461%
Rule of 40 score: 76.8709125001755
Market cap: 62844198912 (Large Cap ($10B-$200B))
P/E ratio: 1.2035522318298668
Debt to equity: 0.2857
Free cash flow (dilution adjusted): 1105269922.8791773
Operating income: 652570694.0874035
Net income: 988174807.1979434
Long score: 9 | Short score: 2
Recommendation: Long
Stock screener scorecard for 0687.HK (annual, report date 2025-12-31)
Altman Z-score: 3.2769877131999237 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 3.43781854831429%
Earnings yield: 6.402592856294122%
Return on net tangible assets: 10.734867059662303%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.426771143358754%
Free cash flow margin: 15.505684290648148%
Revenue growth: -14.051145513984146%
Rule of 40 score: 1.4545387766640019
Market cap: 1026640896 (Small Cap ($300M-$2B))
P/E ratio: 1.863753213367609
Debt to equity: 0.08810000000000001
Free cash flow (dilution adjusted): 41266066.83804627
Operating income: 5383933.161953728
Net income: 7881362.467866324
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 1935.HK (annual, report date 2025-12-31)
Altman Z-score: 1.525891431401876 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 8.77287404486377%
Earnings yield: 4.193525844919461%
Return on net tangible assets: -27.34835751225618%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.2762840603478836%
Free cash flow margin: -77.26764082215364%
Revenue growth: 1.2851799046503465%
Rule of 40 score: -75.98246091750329
Market cap: 1200622464 (Small Cap ($300M-$2B))
P/E ratio: 0.7149742930591259
Debt to equity: 0.22820000000000001
Free cash flow (dilution adjusted): -105152428.57142857
Operating income: 50856714.28571428
Net income: 43180428.571428575
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 1959.T (annual, report date 2026-03-31)
Altman Z-score: 4.602191486027824 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 23.052403147904208%
Earnings yield: 0.05608090382101303%
Return on net tangible assets: 12.312305305036691%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.499869875345892%
Free cash flow margin: 1.5149478495007582%
Revenue growth: -5.965514615475691%
Rule of 40 score: -4.450566765974933
Market cap: 627347161088 (Mega Cap (>= $200B))
P/E ratio: 0.10334587025877849
Debt to equity: 0.08460000000000001
Free cash flow (dilution adjusted): 45126376.376376376
Operating income: 341597847.8478478
Net income: 252139639.63963965
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 2192.HK (annual, report date 2025-12-31)
Altman Z-score: 15.745979895976328 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 4.520630932754664%
Earnings yield: 1.315570056088187%
Return on net tangible assets: 7.766998728210228%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.485292349232559%
Free cash flow margin: 18.588347050167016%
Revenue growth: 19.915826444642533%
Rule of 40 score: 38.50417349480955
Market cap: 5549690368 (Mid Cap ($2B-$10B))
P/E ratio: 2.3233254110685357
Debt to equity: 0.0021
Free cash flow (dilution adjusted): 17052285.714285713
Operating income: 24635714.285714287
Net income: 49698428.571428575
Long score: 9 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 3773.HK (annual, report date 2025-12-31)
Altman Z-score: 5.5364187382717915 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 10.074701121259373%
Earnings yield: 0.4750192428798207%
Return on net tangible assets: 8.969840672142338%
Capitalized R&D asset: 3358095.516361565
ROCI (R&D adjusted): 9.456316248080675%
Rosenberg metric: -0.11179093075493458
Free cash flow margin: 87.65597351633355%
Revenue growth: 27.19980112272367%
Rule of 40 score: 114.85577463905722
Market cap: 1078999936 (Small Cap ($300M-$2B))
P/E ratio: 2.570694087403599
Debt to equity: 0.1243
Free cash flow (dilution adjusted): 19178000
Operating income: 4845571.428571428
Net income: 4097571.4285714286
Long score: 11 | Short score: 2
Recommendation: Long
Stock screener scorecard for 3905.T (annual, report date 2026-03-31)
Altman Z-score: 6.740292600873959 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 31.313849636086395%
Earnings yield: 0.029772253259574836%
Return on net tangible assets: -7.570368219736083%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 18.045510214086747%
Free cash flow margin: -29.81751426675964%
Revenue growth: 968.9863855788187%
Rule of 40 score: 939.1688713120591
Market cap: 74323959808 (Large Cap ($10B-$200B))
P/E ratio: 0.08796020641476193
Debt to equity: 0.027999999999999997
Free cash flow (dilution adjusted): -62688857.6076076
Operating income: 22176445.195195194
Net income: 17561761.761761762
Long score: 10 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 5929.T (annual, report date 2026-03-31)
Altman Z-score: 5.106833294069055 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 26.022273033837244%
Earnings yield: 0.06789596889203574%
Return on net tangible assets: 23.169496556092394%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 19.922472224251226%
Free cash flow margin: 9.292399714247662%
Revenue growth: -6.629612039044688%
Rule of 40 score: 2.6627876752029733
Market cap: 790834380800 (Mega Cap (>= $200B))
P/E ratio: 0.07858088912776412
Debt to equity: 0.16260000000000002
Free cash flow (dilution adjusted): 384109109.1091091
Operating income: 494844844.8448448
Net income: 376426426.4264264
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 7734.T (annual, report date 2026-03-31)
Altman Z-score: 8.448560915259204 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 16.899861753343977%
Earnings yield: 0.061168283705635804%
Return on net tangible assets: 12.822659093272538%
Capitalized R&D asset: 33482799.35207998
ROCI (R&D adjusted): 13.129184134523921%
Rosenberg metric: 0.31395375715592516
Free cash flow margin: 15.045221680397864%
Revenue growth: 5.389745191090953%
Rule of 40 score: 20.434966871488818
Market cap: 151140483072 (Large Cap ($10B-$200B))
P/E ratio: 0.08400748766793097
Debt to equity: 0.0453
Free cash flow (dilution adjusted): 51969488.23823824
Operating income: 77734171.67167167
Net income: 62295814.56456456
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 9961.HK (quarterly, report date 2026-03-31)
Altman Z-score: 1.6472359359843636 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 8.018455659667882%
Earnings yield: 1.754663099689415%
Return on net tangible assets: 2.807583254572747%
Capitalized R&D asset: 6301731831.3953495
ROCI (R&D adjusted): 2.064965407762335%
Rosenberg metric: 0.15396488148849533
Revenue growth: 4.444451156950822%
Rule of 40 score: 4.444451156950822
Market cap: 215737008128 (Mega Cap (>= $200B))
P/E ratio: 0.9272895870834016
Debt to equity: 0.1882
Operating income: 3058139534.883721
Net income: 1957364341.0852714
Long score: 2 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for ATKR (quarterly, report date 2026-03-31)
Altman Z-score: 2.093277779955066 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 1.2606763311633544%
Earnings yield: 0.7170740883297841%
Return on net tangible assets: -11.10251816830266%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.9994282353487014%
Free cash flow margin: 0.12989197089872936%
Revenue growth: 11.567268910895923%
Rule of 40 score: 11.697160881794652
Market cap: 2587585280 (Mid Cap ($2B-$10B))
Debt to equity: 0.7173999999999999
Free cash flow (dilution adjusted): 950000
Operating income: 21972000
Net income: -124073000
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for BHARTIARTL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.1663456085516017 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 11.57698574549455%
Earnings yield: 0.013831870954689657%
Return on net tangible assets: -35.00859559171089%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.726146901104976%
Free cash flow margin: 29.242080630949456%
Revenue growth: -2.394208956056892%
Rule of 40 score: 26.847871674892563
Market cap: 11842219933696 (Mega Cap (>= $200B))
P/E ratio: 0.42336009008373043
Debt to equity: 0.9972
Free cash flow (dilution adjusted): 1716320474.7774482
Operating income: 1891490038.1517591
Net income: 980012717.2530733
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for BHARTIARTL.NS (annual, report date 2026-03-31)
Altman Z-score: 2.746838900611246 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 43.99534795626612%
Earnings yield: 0.05256445752941943%
Return on net tangible assets: -128.03367183807163%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 17.96050215294274%
Free cash flow margin: 35.64426314671844%
Revenue growth: 10.560204285945298%
Rule of 40 score: 46.20446743266373
Market cap: 11842219933696 (Mega Cap (>= $200B))
P/E ratio: 0.42336009008373043
Debt to equity: 0.9972
Free cash flow (dilution adjusted): 7969446799.491309
Operating income: 7188119966.087325
Net income: 3584442560.406952
Long score: 8 | Short score: 3
Recommendation: Long
Stock screener scorecard for BOKU.L (annual, report date 2025-12-31)
Altman Z-score: 0.8866822184553664 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 21.089634533789745%
Earnings yield: 36.2540598028366%
Return on net tangible assets: 22.04144979253988%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.162513594023359%
Free cash flow margin: 48.459066279557206%
Revenue growth: 40.282556891302484%
Rule of 40 score: 88.7416231708597
Market cap: 307908928 (Small Cap ($300M-$2B))
P/E ratio: 0.945945945945946
Debt to equity: 0.0355
Free cash flow (dilution adjusted): 84356756.75675677
Operating income: 27808108.108108107
Net income: 16582432.432432432
Long score: 13 | Short score: 2
Recommendation: Long
Stock screener scorecard for BSX (quarterly, report date 2026-03-31)
Altman Z-score: 2.6892464596920624 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 13.111545988258316%
Earnings yield: 1.4182292533127128%
Return on net tangible assets: 567.4157303370787%
Capitalized R&D asset: 1066850000
ROCI (R&D adjusted): 2.5828185037524314%
Rosenberg metric: -0.11423550087873462
Free cash flow margin: 1.6913319238900635%
Revenue growth: -1.5701853953840332%
Rule of 40 score: 0.12114652850603025
Market cap: 65771216896 (Large Cap ($10B-$200B))
P/E ratio: 26.25523012552301
Debt to equity: 0.4225
Free cash flow (dilution adjusted): 88000000
Operating income: 1072000000
Net income: 1341000000
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for DENTA.NS (quarterly, report date 2026-03-31)
Altman Z-score: 22.568169995008994 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 2.8006546018724165%
Earnings yield: 0.013623959928803234%
Return on net tangible assets: 2.0130235234122678%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.289698312373754%
Revenue growth: -1.6789403683124384%
Rule of 40 score: -1.6789403683124384
Market cap: 8988555264 (Mid Cap ($2B-$10B))
P/E ratio: 0.10391239530855069
Debt to equity: 0.0264
Operating income: 1117210.6824925817
Net income: 965451.4624841034
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for DENTA.NS (annual, report date 2026-03-31)
Altman Z-score: 23.402018548405746 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 19.591564562234996%
Earnings yield: 0.09530439432267068%
Return on net tangible assets: 13.278937894181691%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 16.017245498577356%
Free cash flow margin: -13.98320146657667%
Revenue growth: 11.653895595701155%
Rule of 40 score: -2.3293058708755154
Market cap: 8988555264 (Mid Cap ($2B-$10B))
P/E ratio: 0.10391239530855069
Debt to equity: 0.0264
Free cash flow (dilution adjusted): -3710364.561254769
Operating income: 7815281.899109792
Net income: 6454005.934718101
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for EAT.MC (quarterly, report date 2026-03-31)
Altman Z-score: 0.3460821008387421 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0.4271748952600017%
Earnings yield: 0.29473384553599363%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.2953035379635414%
Free cash flow margin: 4.858162051978936%
Revenue growth: -9.508076358296629%
Rule of 40 score: -4.649914306317693
Market cap: 513435328 (Small Cap ($300M-$2B))
P/E ratio: 77.29885057471265
Debt to equity: 4.4784
Free cash flow (dilution adjusted): 32873563.2183908
Operating income: 5977011.494252874
Net income: -19770114.942528736
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for GIII (quarterly, report date 2026-04-30)
Altman Z-score: 2.739866751308055 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 6.39429550970191%
Earnings yield: 6.203847190845004%
Return on net tangible assets: 6.323948603442049%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.001648828613374%
Free cash flow margin: -3.781424802504655%
Revenue growth: -30.52879630013688%
Rule of 40 score: -34.310221102641535
Market cap: 1474560512 (Small Cap ($300M-$2B))
P/E ratio: 10.950704225352114
Debt to equity: 0.1609
Free cash flow (dilution adjusted): -20267000
Operating income: 85235000
Net income: 66534000
Long score: 4 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for GS2C.DE (quarterly, report date 2026-04-30)
Altman Z-score: 2.253414095786748 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 1.383568749501237%
Earnings yield: 3.141300154410462%
Return on net tangible assets: 6.668834836788141%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.3713664227803046%
Free cash flow margin: 38.836346222913924%
Revenue growth: -24.359322647831206%
Rule of 40 score: 14.477023575082718
Market cap: 8444369408 (Mid Cap ($2B-$10B))
P/E ratio: 20.674024438312973
Debt to equity: 0.7426999999999999
Free cash flow (dilution adjusted): 324400000
Operating income: 138700000
Net income: 389600000
Long score: 5 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for LOPE (quarterly, report date 2026-03-31)
Altman Z-score: 13.133341470884131 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 18.54686258395553%
Earnings yield: 2.710642383502768%
Return on net tangible assets: 20.117828107755205%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.508725398595496%
Free cash flow margin: 24.76551366757352%
Revenue growth: 0.20803650537616958%
Rule of 40 score: 24.97355017294969
Market cap: 3710410752 (Mid Cap ($2B-$10B))
P/E ratio: 21.28035043804756
Debt to equity: 0.1496
Free cash flow (dilution adjusted): 76466000
Operating income: 95462000
Net income: 75348000
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for MIND (quarterly, report date 2026-04-30)
Altman Z-score: 1.3783923938232612 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0.03512028698291649%
Earnings yield: 0.041545176699945535%
Return on net tangible assets: -0.5788458165234169%
Capitalized R&D asset: 737610
ROCI (R&D adjusted): -0.18267370485715273%
Rosenberg metric: 0.27249357326478146
Free cash flow margin: -19.768403639371382%
Revenue growth: -1.2658227848101267%
Rule of 40 score: -21.034226424181508
Market cap: 50444256 (Micro Cap ($50M-$300M))
P/E ratio: 38.8125
Debt to equity: 0.0219
Free cash flow (dilution adjusted): -1912000
Operating income: 14000
Net income: -411000
Long score: 2 | Short score: 14
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for NELCO.NS (annual, report date 2026-03-31)
Altman Z-score: 5.62287713025586 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 12.64902918133303%
Earnings yield: 0.005410687015726144%
Return on net tangible assets: 1.875553408999437%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.962261453791725%
Free cash flow margin: -2.6157860404435747%
Revenue growth: -8.811829715647551%
Rule of 40 score: -11.427615756091125
Market cap: 15683086336 (Large Cap ($10B-$200B))
P/E ratio: 3.702726782490446
Debt to equity: 0.5654
Free cash flow (dilution adjusted): -849936.4137346334
Operating income: 1180584.9936413735
Net income: 351844.00169563375
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for OGC (quarterly, report date 2026-03-31)
Altman Z-score: 5.654557576602377 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 13.544973544973546%
Earnings yield: 5.291390894617485%
Return on net tangible assets: 8.077132220688501%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.53892173669664%
Free cash flow margin: 35.310498468393206%
Revenue growth: 7.873542677592163%
Rule of 40 score: 43.18404114598537
Market cap: 5303149056 (Mid Cap ($2B-$10B))
P/E ratio: 9.44277108433735
Debt to equity: 0.022000000000000002
Free cash flow (dilution adjusted): 182446043.16546765
Operating income: 257841726.61870506
Net income: 169352517.98561153
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for PRIVISCL.NS (annual, report date 2026-03-31)
Altman Z-score: 6.839976438660499 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 25.879188890737982%
Earnings yield: 0.03576202890212434%
Return on net tangible assets: 10.895306288917787%
Capitalized R&D asset: 584356.1058686206
ROCI (R&D adjusted): 24.440136021826554%
Rosenberg metric: 112.84239379966344
Free cash flow margin: 9.051376056264553%
Revenue growth: 10.154773343488662%
Rule of 40 score: 19.206149399753215
Market cap: 140438224896 (Large Cap ($10B-$200B))
P/E ratio: 0.37629490155339496
Debt to equity: 0.7440000000000001
Free cash flow (dilution adjusted): 24381581.178465452
Operating income: 53807937.68545994
Net income: 34711456.1254769
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for PRIVISCL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 5.886806875504534 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 7.327114798409018%
Earnings yield: 0.010125220396056008%
Return on net tangible assets: 9.402578334539227%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.92074941321654%
Revenue growth: 13.52532394302543%
Rule of 40 score: 13.52532394302543
Market cap: 140438224896 (Large Cap ($10B-$200B))
P/E ratio: 0.37629490155339496
Debt to equity: 0.7440000000000001
Operating income: 15234516.744383214
Net income: 9973039.423484527
Long score: 3 | Short score: 2
Recommendation: Neutral